Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
   
 
  Blog Calendar  
 
SuMoTuWeThFrSa
  
1
2345
6
7
8
9
10
1112
13141516171819
20212223242526
2728293031  
 
  Archive  
 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Five Signs a Loved One is Abusing Painkillers

Catasys Health - Tuesday, May 01, 2012

By HeathPop Staff
Abusing painkillers is a big problem in the U.S. - about 12 million people said they used painkillers for non-medical reasons in the past year, according to recent CDC estimates.

A new study found rates of newborns born addicted to opiate drugs tripled over the past decade, driven by legal and illegal use of opioids like hydrocodone and oxycodone, CBS News reported. The number of newborns with withdrawal symptoms increased from a little more than 1 per 1,000 babies in 2000 to more than 3 per 1,000 in 2009, according to the study.
 » More



OxyContin Replacement May Not Solve Abuse

Catasys Health - Tuesday, February 28, 2012

Thousands of Addicts Face Involuntary Withdrawal

By Prithi Yelaja, CBC News
The move to replace the prescription painkiller OxyContin with a newer formulation less prone to misuse won’t solve the crisis of widespread abuse, experts say, unless there is additional training for physicians and treatment for addicts.

Following a similar move in the U.S. in 2010, Purdue Pharma will stop manufacturing OxyContin in Canada and replace it —starting Thursday — with OxyNeo pills, which have been treated to make them extremely difficult to break down.
 » More



CDC director: We can reduce prescription drug overdoses

Catasys Health - Friday, February 24, 2012

By Dr. Frieden
Thirty years ago, I attended medical school in New York. In the key lecture on pain management, the professor told us confidently that patients who received prescription narcotics for pain would not become addicted.

While pain management remains an essential patient right, a generation of health care professionals, patients, and families have learned the hard way how deeply misguided that assertion was. Narcotics - both illegal and legal - are dangerous drugs that can destroy lives and communities.


Millions of Americans struggle with substance abuse. Across the United States, overdoses involving opioid painkillers - a class of drugs with narcotic effects that includes hydrocodone, methadone, oxycodone - have skyrocketed in the past decade.
 » More



Opioids Are Rarely the Answer

Catasys Health - Wednesday, February 15, 2012

Doctors need access to education and training programs that are free of industry bias.

By Andrew Kolodny; President of Physicians for Responsible Opioid Prescribing and chairman of the department of psychiatry at Maimonides Medical Center in New York City

Doctors have contributed to an epidemic of overdose deaths and addiction by overprescribing opioids. We didn’t do this out of malicious intent. For most of us, it was a desire to treat pain more compassionately that led to overprescribing. To bring this public health crisis under control, doctors must prescribe more cautiously.

In response to an industry-funded campaign, sales for opioids increased exponentially. Doctors were taught that unrealistic fear of addiction was resulting in needless suffering and that opioids would provide long-term relief of chronic pain. Doctors were misinformed.
 » More



The New Panic Over Prescription Painkillers

Catasys Health - Wednesday, February 08, 2012

By Radley Balko; Senior Writer and Investigative Reporter, The Huffington Post
"I don't want to be doped up all the time," says Mary Maston. "I want to be able to function. I have to be able to function for my kids. But the pain prevents me from doing so."

In 2008, Maston, 37, was diagnosed with Medullary Sponge Kidney, a congenital disorder that causes her to form large, painful kidney stones. She has since had three lithotripsy surgeries, all of which she says were unsuccessful, and has had to be hospitalized to drain the blood from her kidneys. She has also been diagnosed with stage two Chronic Kidney Disease.


For the first few years after her diagnosis, Maston lived in Tennessee. There, she says, "my doctor was pretty good about writing me a prescription for pain medication when I needed one." But in March 2011, Maston and her family moved to Florida to be closer to her husband's family, and her condition worsened. Florida doctors, she says, were much less willing to prescribe the level of medication she needed. In September, the daily pain from her condition forced her to quit her job. She says she's been to the emergency room seven times in the last eighth months, all due to overwhelming pain.
 » More



As painkiller addiction rises, stronger brand hits market

Catasys Health - Thursday, February 02, 2012

By Amy Bell
Two years ago, 28 percent of patients admitted to the Dawn Farm rehabilitation center in Ann Arbor had opiate addictions. Last year, that number rose to 55 percent, said Jim Balmer, president of the organization.

"Opiates overall are dramatically on the rise," he said.


Though the numbers are increasing at an alarming rate, painkillers are still in demand and drug manufacturers are cashing in.


Zogenix, a San Diego-based pharmaceutical company, has plans to apply early this year for U.S. Federal Drug Administration approval of its product, Zohydro. Zogenix is one of four companies that have started testing the pain reliever product. If approved, Zohydro could be on the market beginning in 2013.
 » More





| 1 2 3 4 | Next

 

 
  Tags
 
stress SD members Raymond Anton Health Care Utilization placebo-controlled drinking social network opioid overdose substance dependence costs gabapentin substance dependence hospital overdose dependence issues opioid abuse stratified addiction treatment opioid antagonist PTSD painkillers Opioid Treatment mental illness post-traumatic stress disorder emergency room substance dependence health insurance diabetes alcohol dependence pain medication morphine opioid-drug interactions drug addiction withdrawal alcohol high-utilizing pain killers Journal of Psychopharmacology alcohol drinking recovery OnTrak naloxone craving cocaine behavioral healthcare opiod abuse marijuana health plan smoking methamphetamine SD health insurance Co Occurring Disorders Research Across America health insurance UnitedHealthcare addict vivitrol heroin trauma medical pain pills contract drug abuse opiates alcoholism treatment Opioid Medications randomized hospitalizations medical costs data mining facebook cigarettes behavioral health vicodin anxiety relapse care coaching opiod-based sobriety behavioral healthcare services addiction cocaine treatment flumazenil physician- patient relations Catasys bipolar disorder sober prescriptions OxyContin behavioral health care services substance use disorder behavioral health care binge drinking predictive modeling primary care urine drug screen ADD drug treatment fentanyl Harold Urschel ADHD depression screening communication percocet reduction in craving methamphetamine dependence drug use hydrocodone codeine drug addicts suboxone oxycodone relapse prevention stimulants sugar methadone craving score recovery network opioid chronic pain CIWA double-blind depression reducing craving muscle relaxant over-the-counter substances ER identification health reform mental health reduction in use placebo narcotic nicotine buprenorphine medical and behavioral costs prometa meth alcohol treatment psychosocial
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy
 
  Copyright © 2011 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025